Immunopositivity for CD117 (c-kit protein) is a distinctive immunohistochemical feature of these tumours [8,9], for which tumour size and mitotic activity are the most significant parameters regarding prediction of clinical behavior [10,11]. This evidence concerns the gene KIT and neoplasm.